
Julius Clinical, a Netherlands-based clinical research organisation (CRO), has appointed Bassem Saleh as its new chief executive officer (CEO). Saleh …

Novo Nordisk announced results from its SOUL cardiovascular outcomes trial. Rybelsus (oral semaglutide) significantly reduced the risk of major adverse …

Eli Lilly and Versanis Bio have announced a definitive agreement for Lilly to acquire Versanis, a private clinical-stage biopharmaceutical company …
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact

